1. Home
  2. GOVX vs YDKG Comparison

GOVX vs YDKG Comparison

Compare GOVX & YDKG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo GeoVax Labs Inc.

GOVX

GeoVax Labs Inc.

HOLD

Current Price

$1.76

Market Cap

4.0M

Sector

Health Care

ML Signal

HOLD

Logo Yueda Digital Holding Class A Ordinary Share

YDKG

Yueda Digital Holding Class A Ordinary Share

N/A

Current Price

$0.83

Market Cap

4.6M

ML Signal

N/A

Company Overview

Basic Information
Metric
GOVX
YDKG
Founded
2001
2005
Country
United States
China
Employees
17
17
Industry
Biotechnology: Pharmaceutical Preparations
Advertising
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
4.0M
4.6M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
GOVX
YDKG
Price
$1.76
$0.83
Analyst Decision
Buy
Analyst Count
2
0
Target Price
$200.00
N/A
AVG Volume (30 Days)
132.7K
67.1K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.12
$0.02
52 Week High
$4.40
$3.90

Technical Indicators

Market Signals
Indicator
GOVX
YDKG
Relative Strength Index (RSI) 45.66 42.64
Support Level $0.55 $0.81
Resistance Level $4.40 $1.04
Average True Range (ATR) 0.15 0.07
MACD 0.02 -0.00
Stochastic Oscillator 51.00 9.75

Price Performance

Historical Comparison
GOVX
YDKG

About GOVX GeoVax Labs Inc.

Geovax Labs Inc is a clinical-stage biotechnology company developing human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms. GeoVax's product pipeline includes ongoing human clinical trials for a next-generation COVID-19 vaccine and a gene-directed therapy against head and neck cancers. Additional research and development programs include preventive vaccines against Monkeypox (MPox), hemorrhagic fever viruses (Ebola Zaire, Ebola Sudan, Marburg, and Lassa), and Zika virus, as well as immunotherapies for multiple solid tumors. The Company's key clinical program is GEO-CM04S1, a next-generation COVID-19 vaccine.

About YDKG Yueda Digital Holding Class A Ordinary Share

Yueda Digital Holding is a digital-economy company with a focus on the long-term accumulation of mainstream cryptocurrencies. The business activities of the company include active treasury management of mainstream digital assets, exploration of compliant, risk-managed yield opportunities, such as staking, on-chain liquidity provision, and other conservative market activities, selective investments and partnerships in Web3 infrastructure and applications, and advisory services for enterprises entering the digital-asset economy.

Share on Social Networks: